Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 403 participants.

Also called NCT01068652

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 403 participants (enrolled count) (from the registry)
Sponsor
  • Novo Nordisk Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01068652
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Algeria, Egypt, Morocco, South Africa, Tunisia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01068652. Randomized; no masking; primary purpose treatment. Start 2010-03 (registry gives no type); primary completion 2012-05 (actual). Results posted on 2013-04-08.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs
Condition
Diabetes
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
insulin detemir
Intervention (Drug)
insulin aspart
Intervention (Drug)
biphasic insulin aspart 30
Intervention (Drug)
metformin
Lead sponsor
Novo Nordisk A/S (class: industry)

Record details

Record id
cardio:ct-nct01068652
Content hash
88eddad4c5021c2068873dcc5fd57a44c2374db13a024d029e4f07fe6e2bb443